Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Findings could show how to breach the bacterium's tough cell wall

National Science Foundation : 09 May, 2004  (Company News)
Chemists and biochemists at the University of Wisconsin-Madison, supported in part by the National Science Foundation, have discovered a new chink in the armor of the bacterial family that causes diseases such as tuberculosis and leprosy. The researchers' findings, which are reported today in the online edition of the journal Nature Structural & Molecular Biology, could lead to the development of a new family of antibiotics to treat those afflictions, which claim up to 3 million lives around the world every year. This prospect is especially welcome given the rapid spread of tuberculosis strains that are resistant to existing drugs.
Chemists and biochemists at the University of Wisconsin-Madison, supported in part by the National Science Foundation, have discovered a new chink in the armor of the bacterial family that causes diseases such as tuberculosis and leprosy.

The researchers' findings, which are reported today in the online edition of the journal Nature Structural & Molecular Biology, could lead to the development of a new family of antibiotics to treat those afflictions, which claim up to 3 million lives around the world every year. This prospect is especially welcome given the rapid spread of tuberculosis strains that are resistant to existing drugs.

Microbes that cause tuberculosis and leprosy, and related bacteria, are particularly tough adversaries because of their unique, multilayered cell walls, which render them virtually invulnerable to easy treatment. In the research reported today, however, UW chemist Laura L. Kiessling and her team have detailed the workings of a key enzyme the bacteria use to maintain the integrity of their cell walls. Enzymes are proteins that initiate chemical reactions within bacteria, plant and animal cells.

'We've figured out how this enzyme works,' says Kiessling. 'If you knock it out, the bacteria aren't viable.'

Kiessling cautions that it takes years and many millions of dollars to develop a new drug. Nonetheless, this discovery opens up a whole new line of attack against TB and leprosy. 'Because we understand the mechanism better, we can design inhibitors specific to this enzyme.'

In the paper, Kiessling acknowledges support from an NSF Young Investigator award. 'It is gratifying to see that seminal funding from NSF has helped Dr. Kiessling develop into a leading organic chemist,' says NSF program officer, George Rubottom. 'Her research, which covers the spectrum from synthesis to enzyme mechanism, highlights the unique role chemistry can play in solving extremely important biological problems.'

A more detailed press release about this work will be available after the embargo lifts on the University of Wisconsin-Madison web site: http://www.news.wisc.edu/
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo